Rochel Soffer - 16 Apr 2024 Form 3 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
10%+ Owner
Signature
/s/ Rochel Soffer, Sole Member of Alpha Pharma Investments LLC
Issuer symbol
GRTX
Transactions as of
16 Apr 2024
Net transactions value
$0
Form type
3
Filing time
16 May 2024, 10:26:45 UTC
Next filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GRTX Common Stock 3,178,137 16 Apr 2024 Direct F1, F2
holding GRTX Common Stock 2,750,000 16 Apr 2024 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the 5,928,137 Shares reported, 3,178,137 shares of common stock are held by Rochel Soffer individually and 2,750,000 shares of common stock are held by Alpha Pharma Investments LLC (collectively, the "Reporting Persons"). Rochel Soffer, as the sole member and beneficiary of Alpha Pharma Investments LLC has voting and dispositive power of Alpha Pharma Investments LLC.
F2 The Reporting Persons disclaims beneficial ownership of all securities owned by Yair Schneid, the spouse of Rochel Soffer, except to the extent of their pecuniary interest therein, if any.